170 related articles for article (PubMed ID: 27598026)
61. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.
Mezei AK; Armstrong HL; Pedersen HN; Campos NG; Mitchell SM; Sekikubo M; Byamugisha JK; Kim JJ; Bryan S; Ogilvie GS
Int J Cancer; 2017 Aug; 141(3):437-446. PubMed ID: 28297074
[TBL] [Abstract][Full Text] [Related]
62. The Pap Test: 20th Century Success Story, 21st Century Has-Been.
Greene J
Manag Care; 2018 Feb; 27(2):24-27. PubMed ID: 29451465
[TBL] [Abstract][Full Text] [Related]
63. Cervical Cancer Screening: More Choices in 2019.
Sawaya GF; Smith-McCune K; Kuppermann M
JAMA; 2019 May; 321(20):2018-2019. PubMed ID: 31135834
[No Abstract] [Full Text] [Related]
64. Pap smear accuracy for the diagnosis of cervical precancerous lesions.
Nkwabong E; Laure Bessi Badjan I; Sando Z
Trop Doct; 2019 Jan; 49(1):34-39. PubMed ID: 30222058
[TBL] [Abstract][Full Text] [Related]
65. New biological research and understanding of Papanicolaou's test.
Smith ER; George SH; Kobetz E; Xu XX
Diagn Cytopathol; 2018 Jun; 46(6):507-515. PubMed ID: 29663734
[TBL] [Abstract][Full Text] [Related]
66. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Tsiachristas A; Gittins M; Kitchener H; Gray A
J Med Screen; 2018 Jun; 25(2):99-109. PubMed ID: 28530515
[TBL] [Abstract][Full Text] [Related]
67. Global strategies for cervical cancer prevention and screening.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Aug; 71(4):313-320. PubMed ID: 30808155
[TBL] [Abstract][Full Text] [Related]
68. Screening for Cervical Cancer.
Ngo-Metzger Q; Adsul P
Am Fam Physician; 2019 Feb; 99(4):253-254. PubMed ID: 30763054
[No Abstract] [Full Text] [Related]
69. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
[TBL] [Abstract][Full Text] [Related]
70. Comparison of conventional Pap smear and liquid-based cytology: A study of cervical cancer screening at a tertiary care center in Bihar.
Pankaj S; Nazneen S; Kumari S; Kumari A; Kumari A; Kumari J; Choudhary V; Kumar S
Indian J Cancer; 2018; 55(1):80-83. PubMed ID: 30147099
[TBL] [Abstract][Full Text] [Related]
71. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
Musa J; Achenbach CJ; O'Dwyer LC; Evans CT; McHugh M; Hou L; Simon MA; Murphy RL; Jordan N
PLoS One; 2017; 12(9):e0183924. PubMed ID: 28873092
[TBL] [Abstract][Full Text] [Related]
72. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
Schneider V
Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
[TBL] [Abstract][Full Text] [Related]
73. Educational Interventions for Cervical Cancer Screening Behavior of Women: A Systematic Review.
Saei Ghare Naz M; Kariman N; Ebadi A; Ozgoli G; Ghasemi V; Rashidi Fakari F
Asian Pac J Cancer Prev; 2018 Apr; 19(4):875-884. PubMed ID: 29693331
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.
Shin HY; Lee B; Hwang SH; Lee DO; Sung NY; Park JY; Jun JK
J Gynecol Oncol; 2019 Sep; 30(5):e76. PubMed ID: 31328458
[TBL] [Abstract][Full Text] [Related]
75. Cervical Cancer Screening.
Rerucha CM; Caro RJ; Wheeler VL
Am Fam Physician; 2018 Apr; 97(7):441-448. PubMed ID: 29671553
[TBL] [Abstract][Full Text] [Related]
76. Pathway to the Papanicolaou smear: The development of cervical cytology in twentieth-century America and implications in the present day.
Swailes AL; Hossler CE; Kesterson JP
Gynecol Oncol; 2019 Jul; 154(1):3-7. PubMed ID: 30995961
[TBL] [Abstract][Full Text] [Related]
77. Cervical Cancer and Its Precursors: A Preventative Approach to Screening, Diagnosis, and Management.
Stumbar SE; Stevens M; Feld Z
Prim Care; 2019 Mar; 46(1):117-134. PubMed ID: 30704652
[TBL] [Abstract][Full Text] [Related]
78. Comparison of the Accuracy of Papanicolaou Test Cytology, Visual Inspection With Acetic Acid, and Visual Inspection With Lugol Iodine in Screening for Cervical Neoplasia in Southeast Nigeria.
Egede J; Ajah L; Ibekwe P; Agwu U; Nwizu E; Iyare F
J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241249
[TBL] [Abstract][Full Text] [Related]
79. Pap tests in the diagnosis of cervical cancer: Help or hinder?
Philp L; Jembere N; Wang L; Gao J; Maguire B; Kupets R
Gynecol Oncol; 2018 Jul; 150(1):61-66. PubMed ID: 29773301
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
